What Is the True Cost of Diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies?
Unfair Gaps methodology documents how diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies drains retail groceries profitability.
Diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies is a fraud & abuse in retail groceries: Insufficient physical security (e.g., non‑segregated safes, shared keys), lack of real‑time perpetual inventory reconciliation, and inadequate segregation of duties and oversight, which enables both e. Loss: $25,000–$100,000+ per incident at a single pharmacy when diversion occurs over months (lost inventory at acquisition cost, investigation expense, writ.
Diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies is a fraud & abuse in retail groceries. Unfair Gaps research: Insufficient physical security (e.g., non‑segregated safes, shared keys), lack of real‑time perpetual inventory reconciliation, and inadequate segregation of duties and oversight, which enables both e. Impact: $25,000–$100,000+ per incident at a single pharmacy when diversion occurs over months (lost inventory at acquisition cost, investigation expense, writ. At-risk: Controlled substances stored in shared safes or cabinets with broad key/access code distribution amo.
What Is Diversion, theft, and inventory shrink of and Why Should Founders Care?
Diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies is a critical fraud & abuse in retail groceries. Unfair Gaps methodology identifies: Insufficient physical security (e.g., non‑segregated safes, shared keys), lack of real‑time perpetual inventory reconciliation, and inadequate segregation of duties and oversight, which enables both e. Impact: $25,000–$100,000+ per incident at a single pharmacy when diversion occurs over months (lost inventory at acquisition cost, investigation expense, writ. Frequency: ongoing; dea diversion‑control reports describe controlled‑substance losses as a routine compliance finding, and chains may experience multiple incidents per year across their store network.
How Does Diversion, theft, and inventory shrink of Actually Happen?
Unfair Gaps analysis traces root causes: Insufficient physical security (e.g., non‑segregated safes, shared keys), lack of real‑time perpetual inventory reconciliation, and inadequate segregation of duties and oversight, which enables both external diversion (burglaries, robberies) and internal theft or falsified returns.. Affected actors: Pharmacy manager, Pharmacists, Pharmacy technicians, Store managers (responsible for physical security), Loss‑prevention and asset‑protection teams, C. Without intervention, losses recur at ongoing; dea diversion‑control reports describe controlled‑substance losses as a routine compliance finding, and chains may experience multiple incidents per year across their store network frequency.
How Much Does Diversion, theft, and inventory shrink of Cost?
Per Unfair Gaps data: $25,000–$100,000+ per incident at a single pharmacy when diversion occurs over months (lost inventory at acquisition cost, investigation expense, write‑offs) plus potential six‑ to seven‑figure civil . Frequency: ongoing; dea diversion‑control reports describe controlled‑substance losses as a routine compliance finding, and chains may experience multiple incidents per year across their store network. Companies addressing this proactively report significant savings vs reactive approaches.
Which Companies Are Most at Risk?
Unfair Gaps research identifies highest-risk profiles: Controlled substances stored in shared safes or cabinets with broad key/access code distribution among front‑store and pharmacy staff, Failure to conduct and reconcile regular cycle counts for C‑II dr. Root driver: Insufficient physical security (e.g., non‑segregated safes, shared keys), lack of real‑time perpetua.
Verified Evidence
Cases of diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies in Unfair Gaps database.
- Documented fraud & abuse in retail groceries
- Regulatory filing: diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies
- Industry report: $25,000–$100,000+ per incident at a single pharmac
Is There a Business Opportunity?
Unfair Gaps methodology reveals diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies creates addressable market. ongoing; dea diversion‑control reports describe controlled‑substance losses as a routine compliance finding, and chains may experience multiple incidents per year across their store network recurrence = recurring revenue. retail groceries companies allocate budget for fraud & abuse solutions.
Target List
retail groceries companies exposed to diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies.
How Do You Fix Diversion, theft, and inventory shrink of? (3 Steps)
Unfair Gaps methodology: 1) Audit — review Insufficient physical security (e.g., non‑segregated safes, shared keys), lack o; 2) Remediate — implement fraud & abuse controls; 3) Monitor — track ongoing; dea diversion‑control reports describe controlled‑substance losses as a routine compliance finding, and chains may experience multiple incidents per year across their store network recurrence.
Get evidence for Retail Groceries
Our AI scanner finds financial evidence from verified sources and builds an action plan.
Run Free ScanWhat Can You Do With This Data?
Next steps:
Find targets
Exposed companies
Validate demand
Customer interview
Check competition
Who's solving this
Size market
TAM/SAM/SOM
Launch plan
Idea to revenue
Unfair Gaps evidence base.
Frequently Asked Questions
What is Diversion, theft, and inventory shrink of?▼
Diversion, theft, and inventory shrink of controlled substances in grocery‑based pharmacies is fraud & abuse in retail groceries: Insufficient physical security (e.g., non‑segregated safes, shared keys), lack of real‑time perpetual inventory reconcil.
How much does it cost?▼
Per Unfair Gaps data: $25,000–$100,000+ per incident at a single pharmacy when diversion occurs over months (lost inventory at acquisition cost, investigation expense, writ.
How to calculate exposure?▼
Multiply frequency by avg loss per incident.
Regulatory fines?▼
See full evidence database for regulatory cases.
Fastest fix?▼
Audit, remediate Insufficient physical security (e.g., non‑segregated safes, , monitor.
Most at risk?▼
Controlled substances stored in shared safes or cabinets with broad key/access code distribution among front‑store and pharmacy staff, Failure to cond.
Software solutions?▼
Integrated risk platforms for retail groceries.
How common?▼
ongoing; dea diversion‑control reports describe controlled‑substance losses as a routine compliance finding, and chains may experience multiple incidents per year across their store network in retail groceries.
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Get financial evidence, target companies, and an action plan — all in one scan.
Sources & References
Related Pains in Retail Groceries
Excess labor, overtime, and security spending to stay DEA‑compliant
Delayed reimbursement from DEA‑related holds, investigations, and PDMP verification
Bottlenecks from manual DEA record‑keeping and outdated dispensing workflows
Lost prescriptions and shoppers due to DEA‑driven refusal‑to‑fill policies and long waits
Civil penalties and settlements for controlled‑substance dispensing violations in supermarket pharmacies
Dispensing errors leading to refunds, malpractice payouts, and corrective work in supermarket pharmacies
Methodology & Limitations
This report aggregates data from public regulatory filings, industry audits, and verified practitioner interviews. Financial loss estimates are statistical projections based on industry averages and may not reflect specific organization's results.
Disclaimer: This content is for informational purposes only and does not constitute financial or legal advice. Source type: Open sources, regulatory filings.